CDC vaccine panel to meet in March after delay
Source: SeekingAlpha
2026-02-24 12:06:38 ET
More on Pfizer, Merck, etc.
- Merck: Why Investors Should Remain Bullish Despite Patent Risks
- Pfizer: A Risky 6.3% Yield For Income-Oriented Investors
- Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades)
- GSK inks licensing deal worth up to $1B with China’s Frontier Bio
- Pfizer strikes $495M deal for obesity drug rights in China
Read the full article on Seeking Alpha
For further details see:
CDC vaccine panel to meet in March after delay
BioNTech SE
NASDAQ: BNTX
BNTX Trading
0.97% G/L:
$100.325 Last:
97,946 Volume:
$99 Open:
BNTX Latest News
February 25, 2026 09:00:00 am
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
February 24, 2026 06:45:00 am
BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026
January 28, 2026 09:15:00 am
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
BNTX Stock Data
$26,377,590,776
95,508,380
N/A
104
N/A
Biotechnology & Life Sciences
Healthcare
DE
Mainz
